403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Biovaxys Technology Corp
(MENAFN- Baystreet) 09:38 AM EST - BioVaxys Technology Corp : Along with SpayVac for Wildlife, Inc. are pleased to jointly announce an expansion of the Fields of Use in the current License Agreement to include commercial aquaculture, plus the farm-raised fish market. With this expansion in the Fields of Use, SpayVac-for-Wildlife's markets now include its no-booster fertility-control vaccines for aquaculture as well as overabundant feral/wild/invasive animals, and select production and companion animals, which significantly increases SpayVac's global revenue potential. BioVaxys Technology Corp
shares C are trading off $0.02 at $0.03.
Full Press Release:
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research
More Story
Comments
No comment